| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/04/2007 | CN1307997C 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating pulmonary fibrosis |
| 04/04/2007 | CN1307996C Composition for treating hyperlipemia |
| 04/04/2007 | CN1307995C Gatifloxacin eye drop and its preparing method |
| 04/04/2007 | CN1307994C Qilaxitong preparation |
| 04/04/2007 | CN1307993C Macrolides-containing pharmaceutical compositions |
| 04/04/2007 | CN1307992C Eye drops containing tetrazole derivative |
| 04/04/2007 | CN1307991C Benzopyrany/derivatives and antiallergic agent |
| 04/04/2007 | CN1307990C Triglyceride depressant composition |
| 04/04/2007 | CN1307989C Use of phytanic acid for treating diabetes |
| 04/04/2007 | CN1307988C Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 04/04/2007 | CN1307987C Novel usage of alkannin |
| 04/04/2007 | CN1307986C Vaginal effervescent tablets for treating woman's inflammation and their preparation |
| 04/04/2007 | CN1307971C Antimycotic nail varnish composition |
| 04/04/2007 | CA2570755A1 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 04/04/2007 | CA2521272A1 Capsules comprising topiramate |
| 04/03/2007 | US7200531 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 04/03/2007 | US7199269 Method for producing stable solutions of phenolic substances and resulting solutions |
| 04/03/2007 | US7199268 Process for the production of dendritic trimesic acid triamides |
| 04/03/2007 | US7199265 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 04/03/2007 | US7199258 reacting naproxen or bromonaproxen with nitroxy compounds such as 4-nitrooxybutyl p-toluenesulfonate, to form nitrooxyalkylesters of naproxen or bromonaproxen |
| 04/03/2007 | US7199247 Amide derivative of amlodipine |
| 04/03/2007 | US7199244 Cyclic amine derivatives and methods of use |
| 04/03/2007 | US7199243 Antilipemic agents; anticholesterol agents; atherosclerosis; cardiovascular disorders; obesity; antidiabetic agents |
| 04/03/2007 | US7199239 Chemical compounds |
| 04/03/2007 | US7199238 Inhibitors of lysophosphatidic acid acyltransferase beta (LPAAT- beta ) activity; cancer screening and therapy |
| 04/03/2007 | US7199234 Nucleotide sequences coding telomerase reverse transcriptase (TRT) for diagnosing and treating cancers; antiproliferative agents |
| 04/03/2007 | US7199232 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 04/03/2007 | US7199228 Nucleotide sequences comprising nebularine, hypoxanthine and uracil; antitumor agents; antiproliferative agents; anticarcinogenic agents; antiinflammatory agents |
| 04/03/2007 | US7199162 Pretreatment before allogenic transplantation of bone marrow or haematopoietic stem cells; may be administered with other chemotherapeutic or immunosuppressive agents; antitumor and anticarcinogenic agents |
| 04/03/2007 | US7199161 Clusianon derivatives; anticarcinogenic, antitumor and viricidal agents; mixture with mitogen-activated protein (MAP) kinase inhibitors |
| 04/03/2007 | US7199160 Antiobestic agents and health foods |
| 04/03/2007 | US7199159 Use of biguanide derivatives for making a medicine having a wound healing effect |
| 04/03/2007 | US7199158 Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 04/03/2007 | US7199157 Use of treprostinil to improve kidney functions |
| 04/03/2007 | US7199156 Composition and method to treat solid tumors |
| 04/03/2007 | US7199155 treating rheumatoid arthritis, graft rejection, cachexia, inflammation, fever, insulin resistance, septic shock, congestive heart failure, inflammatory disease of the central nervous system, inflammatory bowel disease or HIV infection |
| 04/03/2007 | US7199154 Rheumatic diseases, influenza, common cold, pain, dysmenorrhea, headache, toothache, sprains and strains, neuralgia, synovitis,arthritis, osteoarthritis, gout, bursitis, burns, injuries, and inflammation; cardiovascular disorders, anticoagulants |
| 04/03/2007 | US7199153 Pharmaceutical composition comprising paracetamol and niflumic acid |
| 04/03/2007 | US7199152 TNF-α production inhibitor comprising kavalactone as an active ingredient |
| 04/03/2007 | US7199151 DHA-pharmaceutical agent conjugates of taxanes |
| 04/03/2007 | US7199150 Amino alcohol compounds |
| 04/03/2007 | US7199149 Monocyclic and bicyclic lactams as factor Xa inhibitors |
| 04/03/2007 | US7199148 Such as (1-Benzyl-2-hydroxy-3-{isobutyl-[2-oxo-3-(1H-pyrrol-2-ylmethylene)-2,3-dihydro-1H-indole-5-sulfonyl]-amino}-propyl)-carbamic acid hexahydro-furo[2,3-b]furan-3-yl ester; multi-drug resistant HIV infections |
| 04/03/2007 | US7199147 Rho kinase inhibitors |
| 04/03/2007 | US7199146 Imidazolidinedione analogs useful as anticoagulants and antithrombotics |
| 04/03/2007 | US7199145 Derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 04/03/2007 | US7199144 Containing less than about 5000 ppm residual solvent by trituration in water |
| 04/03/2007 | US7199143 3-[4-(3,6-dihydro-2H-thiopyran-4-yl) phenyl]-]5[1H or 2H-1,2,3-triazol-1 or 2-yl] oxazolidin-2-ones; grampositive bactericides for drug resistant bacteria, especially Staphylococcus, Enterococcus, and Streptococcus |
| 04/03/2007 | US7199142 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists |
| 04/03/2007 | US7199141 Such as 1-(aminomethyl)cyclohexane-acetic acid-2-methoxy-4-[(1E)-3-[4-(nitrooxy)butoxy]-3-oxy-1-propenyl]phenyl hydrochloride ester; reduced side effects |
| 04/03/2007 | US7199140 (bis(Phenoxy or phenylsulfonamido)phenylethyl)pyridyl carboxylic acids, esters or amides; antidiabetic agents; obesity; glucokinase agonists |
| 04/03/2007 | US7199139 Medicinal compositions containing diuretic and insulin resistance-improving agent |
| 04/03/2007 | US7199138 Substituted anthranilamides for controlling invertebrate pests |
| 04/03/2007 | US7199137 Treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy |
| 04/03/2007 | US7199136 Antiinflammatory agents, neutrophil elastase inhibitors; chronic obstructive pulmonary diseases |
| 04/03/2007 | US7199135 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity |
| 04/03/2007 | US7199134 Hydroxamic acid compounds and methods of use thereof |
| 04/03/2007 | US7199133 Antitumor agenst; thrombosis; arteriosclerosis; cardiovascular disorders; antiinflammatory agents |
| 04/03/2007 | US7199132 For therapy of neurodegenerative disease, psychiatric dysfunction, dopamine dysfunction, cocaine abuse and clinical dysfunction |
| 04/03/2007 | US7199131 Administration of N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide to induce interferon-alpha biosynthesis or as a viricide or anticarcinogenic agent |
| 04/03/2007 | US7199130 Substituted 5,6,6a, 11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonists |
| 04/03/2007 | US7199129 Derivatives of morphine-like opioid compounds |
| 04/03/2007 | US7199128 8-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents |
| 04/03/2007 | US7199127 (2-chloropurin-9-yl)-tetrahydrothiophene-3,4-diols; anticarcinogenic agents selective to A3 adenosine receptors; breast cancer |
| 04/03/2007 | US7199126 P38 MAP kinase; enzyme inhibitors; antiinflammatory agents; cardiovascular disorders |
| 04/03/2007 | US7199125 Spiro-cyclic compounds useful as anti-inflammatory agents |
| 04/03/2007 | US7199124 Antiinflammatory agents; antiarthritic agents; immunomoderators |
| 04/03/2007 | US7199123 Pyrazine compounds as transforming growth factor (TGF) compounds |
| 04/03/2007 | US7199122 Administering 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione and/or metabolite thereof; treating neoplastic diseases, atherosclerosis, restenosis, rheumatoid arthritis, Crohn's disease, diabetic retinopathy, psoriasis, and endometriosis |
| 04/03/2007 | US7199121 Protein tyrosine phosphatase inhibitor |
| 04/03/2007 | US7199120 Pyrazolo-pyridine derivatives as antiherpes agents |
| 04/03/2007 | US7199119 Antiinflammation agents |
| 04/03/2007 | US7199118 potent and highly efficacious in potentiating AMPA-responses, show good lipophilicity and hence have good physicochemical properties, in particular ability to cross the blood/brain barrier |
| 04/03/2007 | US7199117 2-(substituted phenyl)imidazo[1,2-a]pyridine compounds; use to treat disorders mediated by the histamine H3 receptor such as sleep disorders, attention deficit hyperactivity disorder, and learning and memory disorders; 2-[4-[4-Pyrrolidinobut-1-ynyl]phenyl]-7-methylimidazo[1,2-a]pyridine for example |
| 04/03/2007 | US7199116 Administering 7-oxo-dehydroepiandrosterone (DHEA) or prodrug incapable of in vivo conversion to testosterone |
| 04/03/2007 | US7199115 inhibitors for 5 alpha -reductase; high potency gestagens; conditions caused by high levels of androgens; acne, hirsutism, alopecia (male type), BPH (benign prostatic hyperplasia) and prostate carcinoma; contraceptives for men and women; (E)-17 alpha -fluoro-3-oxo-estra-4-en-17 beta-carbaldehyde oxime |
| 04/03/2007 | US7199114 Triterpene quaternary salts as biologically active surfactants |
| 04/03/2007 | US7199113 Inhibiting tissue factor-dependent activation of blood-coagulation factors X or IX by contacting the tissue factor with a bisphosphonate blocking agent; anticoagulation |
| 04/03/2007 | US7199112 Use of phospholipid arachidonic acids for increasing muscle mass in humans |
| 04/03/2007 | US7199111 Aqueous ifosfamide compositions for parenteral administration and a process for their preparations |
| 04/03/2007 | US7199110 Method of treatment for spinal cord injury |
| 04/03/2007 | US7199108 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines |
| 04/03/2007 | US7199107 Inhibiting synthesis and function; arresting cellular proliferation |
| 04/03/2007 | US7199106 Lincomycin derivatives possessing antimicrobial activity |
| 04/03/2007 | US7199105 Lincomycin derivatives possessing antibacterial activity |
| 04/03/2007 | US7199104 treatment of alcohol dependence in humans; a portion of the acetylated mannose, gum ghatti, gum tragacanth, and corn starch are predigested from oligosaccharides into monosaccharides prior to administration |
| 04/03/2007 | US7199102 Orally administered peptides synergize statin activity |
| 04/03/2007 | US7199098 Copolymer-1 improvements in compositions of copolymers |
| 04/03/2007 | US7198951 Viral expression vector for use as heterologous gene and/or therapeutic protein delivery tools; genetic vaccine |
| 04/03/2007 | US7198946 Screening for agents effective in decreasing abnormal macrophages associated with amyotrophic lateral sclerosis |
| 04/03/2007 | US7198934 Genetic engineering; gene insertion; culture product |
| 04/03/2007 | US7198922 Synthesizing polyketide fusion protein comprising acyltransferase domain for use as anthelminthic, insecticide, antitumor, immunosuppressant, fungicidal and/or bactericidal agents |
| 04/03/2007 | US7198920 HER-2/neu fusion proteins |
| 04/03/2007 | US7198910 Nucleic acid encoding melanin-concentrating hormone receptor |
| 04/03/2007 | US7198808 Process for extracting compounds from plants |
| 04/03/2007 | US7198803 Sustained release oral preparations |
| 04/03/2007 | US7198802 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient |
| 04/03/2007 | US7198801 topical mixtures of estrogens or progesterones, and drug delivery vehicles comprising alcohols, alcohols-2+ or polyoxyalylene glycols, and permeation enhancer comprising a monoalkyl ether of diethylene glycol |
| 04/03/2007 | US7198800 spray on skin patch drug delivery system; substantially water insoluble film forming agent; film plasticiser agent; water soluble compound; and organic solvent |
| 04/03/2007 | US7198790 Growth differentiation factor-5 |